6533b824fe1ef96bd127ffc1

RESEARCH PRODUCT

Additional mailing phase for FIT after a medical offer phase: The best way to improve compliance with colorectal cancer screening in France

Jean-françois BretagneChristine PietteJean FaivreJean FaivreG. Durand

subject

MaleMedical consultationColorectal cancer[ SDV.CAN ] Life Sciences [q-bio]/Cancer0302 clinical medicineMass ScreeningEarly Detection of Cancermedia_commonGastroenterology[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologieMiddle Aged3. Good healthTest (assessment)Colorectal cancer screeningOccult Blood030220 oncology & carcinogenesisScreening[ SDV.MHEP.HEG ] Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyFemale030211 gastroenterology & hepatologyFranceColorectal NeoplasmsCompliancemedicine.medical_specialtyReminder Systemseducation[SDV.CAN]Life Sciences [q-bio]/CancerCompliance (psychology)03 medical and health sciences[SDV.CAN] Life Sciences [q-bio]/CancermedicineHumansmedia_common.cataloged_instancePostal ServiceEuropean unionUptake rateMass screeningAgedGynecologyHepatologybusiness.industry[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyImmunochemical testmedicine.diseaseColorectal cancer[SDV.MHEP.HEG] Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieFamily medicinePatient Compliance[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusiness

description

International audience; Background: Compliance with colorectal cancer screening is critical to its effectiveness. The organisation of the mass screening programme in France has recently been modified with no evaluation of the consequences.Aims: To evaluate the impact of the way the screening test is delivered on compliance.Patients and Methods: During the first six months of the screening campaign (Ille-Vilaine, Brittany), general practitioners were asked to propose a faecal immunochemical test (FIT), OC-Sensor, to individuals at average risk for colorectal cancer (n = 152,097). A subset of non-participants in the medical phase (n = 13,071) was randomly chosen to receive a reminder that included the screening test or a simple postal reminder without the screening test.Results: Compliance was 31% if the screening test was proposed during a medical consultation. In nonparticipants during the medical phase, it was 45% in those receiving both a reminder and the screening test and 28% amongst those receiving a simple reminder. An estimated overall participation rate of 54% can be expected if non-participants in the medical phase are sent a reminder together with the screening test.Conclusion: In France, a compliance rate above the minimum uptake rate of 45% recommended by European Union experts can be achieved if the FIT is mailed to non-participants after the medical free-offer phase. (c) 2016 Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.

https://doi.org/10.1016/j.dld.2016.09.015